CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers
Authors
Keywords
Cell apoptosis, Chemotherapy-resistant, Paclitaxel, TNBC, Poor prognosis
Journal
Clinical Breast Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-06-23
DOI
10.1016/j.clbc.2021.06.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39
- (2020) Ling Dong et al. iScience
- Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
- (2019) Wei-Siang Liao et al. Acta Biomaterialia
- Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer
- (2019) Rosa Mistica C. Ignacio et al. Oncotarget
- New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx
- (2019) Mohamed Mounir et al. PLoS Computational Biology
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
- (2019) Jing Zhai et al. CANCER LETTERS
- Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer
- (2019) Yulia Liubomirski et al. Frontiers in Immunology
- Triple negative breast cancer: A thorough review of biomarkers
- (2019) Jesse Lopes da Silva et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis
- (2018) Ling Dong et al. ONCOGENE
- Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
- (2018) Jhajaira M. Araujo et al. Scientific Reports
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
- (2018) Mohammad M. Uddin et al. PLoS One
- Recent advances in breast cancer research impacting clinical diagnostic practice
- (2018) Amy E McCart Reed et al. JOURNAL OF PATHOLOGY
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
- (2017) Helen Ha et al. Theranostics
- Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
- (2016) M. M-Rabet et al. ANNALS OF ONCOLOGY
- The CXCL8-CXCR1/2 pathways in cancer
- (2016) Qian Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells
- (2015) Sangmin Kim et al. TUMOR BIOLOGY
- IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
- (2015) Zhen Ning Wee et al. Nature Communications
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
- (2012) Zhi Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
- (2011) Sharon R. Pine et al. JNCI-Journal of the National Cancer Institute
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8
- (2008) K. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started